首页> 外国专利> COMPOSITION FOR TREATING PRIMARY OVARIAN INSUFFICIENCY AND PREMATURE OVARIAN FAILURE COMPRISING VISFATIN AS ACTIVITY INGREDIENT

COMPOSITION FOR TREATING PRIMARY OVARIAN INSUFFICIENCY AND PREMATURE OVARIAN FAILURE COMPRISING VISFATIN AS ACTIVITY INGREDIENT

机译:用于治疗原发性卵巢功能不全和卵巢早衰的组合物,其中以VISFATIN作为活性成分

摘要

The present invention relates to visfatin and to a composition for treating primary ovarian insufficiency and premature ovarian failure comprising visfatin as an active ingredient, and specifically, to a composition for treating primary ovarian insufficiency and premature ovarian failure through the stimulation of a primordial follicle and ovarian stem cell activation signaling pathway. According to an aspect of the present invention for achieving the above object, the present invention provides visfatin and the composition for treating infertility and disability comprising visfatin as the active ingredient. In addition, the activity of PI3K and/or mTOR, which are the activation signal transduction pathways of the primordial follicle and ovarian stem cell, and the activity of the Hippo pathway factor of the primordial follicle and ovarian stem cell increases in a concentration dependent manner.
机译:本发明涉及visfatin以及涉及以visfatin为有效成分的用于治疗原发性卵巢功能不全和卵巢早衰的组合物,尤其涉及一种通过刺激原始卵泡和卵巢来治疗原发性卵巢功能不全和卵巢早衰的组合物。干细胞激活信号通路。根据用于实现上述目的的本发明的一个方面,本发明提供了维斯法定和包含维斯法定作为活性成分的用于治疗不育和致残的组合物。另外,作为原始卵泡和卵巢干细胞的激活信号转导途径的PI3K和/或mTOR的活性,以及​​原始卵泡和卵巢干细胞的Hippo途径因子的活性以浓度依赖性方式增加。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号